Grant: Master's Award: Canada Graduate Scholarships
University of Calgary
$27,000.00
Incidence, description, predictors, and outcomes of unplanned healthcare encounters after ERCP not related to adverse events
FY 2024-25
Summary
Endoscopic retrograde cholangiopancreatography (ERCP) is a well-established procedure that plays a vital role in managing various pancreatic and biliary diseases. Although highly effective, ERCP has a high risk of adverse events (AEs), including post-ERCP pancreatitis, bleeding, infection, and perforation. With an overall reported ERCP-related AE rate of around 10%, there has been a significant drive in recent years to further understand and optimize ERCP outcomes. Recent research has identified key risk factors, as well as specific symptom presentation criteria that greatly help identify and manage typical AEs. However, there are still a significant number of individuals who present to the emergency department (ED) who are experiencing significant post-procedure morbidity that cannot be explained by typical AEs. Studies have identified that between 20-40% of patients undergoing ERCP report significant post-procedural morbidity that often results in unplanned healthcare encounters (UHEs), such as ED visits. This discrepancy in reported AE rates and patient-reported outcomes highlights the need for more research evaluating UHEs after ERCP to inform future measures.
The main objectives of this project is to identify the true burden of UHEs after ERCP, the primary drivers of UHEs, and potential areas for future interventions to support patients and reduce UHEs after ERCPs. This approach aims to pinpoint where and why post-ERCP morbidity is occurring, allowing for specifically tailored measures to be implemented where they are needed most. The goal of this project is to guide both health professionals and decision-makers in making informed decisions at both the patient and systematic level, in an effort to reduce post-ERCP morbidity and improve patient care.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
563441
Name
Abbott-Tate Samuel J
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Incidence, description, predictors, and outcomes of unplanned healthcare encounters after ERCP not related to adverse events
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adverse Events; Biliary Endoscopy; Endoscopic Procedures; Endoscopic Retrograde Cholangiopancreatography; Hepatobiliary Disease; Unplanned Healthcare Encounters
Abstract
Endoscopic retrograde cholangiopancreatography (ERCP) is a well-established procedure that plays a vital role in managing various pancreatic and biliary diseases. Although highly effective, ERCP has a high risk of adverse events (AEs), including post-ERCP pancreatitis, bleeding, infection, and perforation. With an overall reported ERCP-related AE rate of around 10%, there has been a significant drive in recent years to further understand and optimize ERCP outcomes. Recent research has identified key risk factors, as well as specific symptom presentation criteria that greatly help identify and manage typical AEs. However, there are still a significant number of individuals who present to the emergency department (ED) who are experiencing significant post-procedure morbidity that cannot be explained by typical AEs. Studies have identified that between 20-40% of patients undergoing ERCP report significant post-procedural morbidity that often results in unplanned healthcare encounters (UHEs), such as ED visits. This discrepancy in reported AE rates and patient-reported outcomes highlights the need for more research evaluating UHEs after ERCP to inform future measures.
The main objectives of this project is to identify the true burden of UHEs after ERCP, the primary drivers of UHEs, and potential areas for future interventions to support patients and reduce UHEs after ERCPs. This approach aims to pinpoint where and why post-ERCP morbidity is occurring, allowing for specifically tailored measures to be implemented where they are needed most. The goal of this project is to guide both health professionals and decision-makers in making informed decisions at both the patient and systematic level, in an effort to reduce post-ERCP morbidity and improve patient care.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Abbott-Tate, Samuel J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~